| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | SVP, Finance and Accounting
1 company
Ogden Christopher serves as a Chief Financial Officer at CTMX. Across recent SEC filings that breaks down to 0 buys and 9 sells. Those positions are worth an estimated $901K at current prices.
Historically, Ogden Christopher's trades have earned a middling insider score of 50/100 across 7 rated trades. Over a 12-month horizon, 28.6% of those trades were profitable, with an average 12-month return of -15.3%.
The biggest single holding is CTMX (~$901K) as Chief Financial Officer. The recent filings there lean toward selling, a net 49,214 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sell | 1,624 | $3.05 | $4,953.20 | -0.5% | +5.3% | - | |
| Mar 17, 2026 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sell | 19,323 | $6.42 | $124,111.63 | -6.1% | -44.2% | - | |
| Jun 16, 2025 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 12,255 | $2.72 | $33,381.43 | -5.1% | -19.1% | +19.1% | |
| Mar 18, 2025 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sell | 8,551 | $0.60 | $5,122.05 | -4.1% | +307.5% | +628.8% | |
| Aug 20, 2024 | CTMX Cytomx Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 1,984 | $1.23 | $2,438.53 | -1.8% | -30.4% | +58.9% | |
| Mar 19, 2024 | CTMX Cytomx Therapeutics, Inc. | SVP, Finance and Accounting | Sell | 2,971 | $2.09 | $6,196.02 | -3.4% | -37.2% | -69.3% | |
| Dec 20, 2023 | CTMX Cytomx Therapeutics, Inc. | SVP, Finance and Accounting | Sell | 1,990 | $1.38 | $2,747.39 | -3.9% | +62.7% | -17.9% | |
| Mar 16, 2023 | CTMX Cytomx Therapeutics, Inc. | SVP, Finance and Accounting | Sell | 516 | $1.98 | $1,021.32 | -1.3% | -19.1% | +6.7% |